These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis. Craig JC; Haire M; Merrett JD Clin Immunol Immunopathol; 1988 Sep; 48(3):253-60. PubMed ID: 2841052 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis. Allen JC; Sheremata W; Cosgrove JB; Osterland K; Shea M Neurology; 1976 Jun; 26(6 PT 1):579-83. PubMed ID: 1084494 [TBL] [Abstract][Full Text] [Related]
5. Cellular immunity in multiple sclerosis. Platz P Acta Neurol Scand Suppl; 1977; 63():133-44. PubMed ID: 300538 [No Abstract] [Full Text] [Related]
6. Cellular immunology in multiple sclerosis. A review through 1984. Baumhefner RW; Tourtellotte WW Concepts Immunopathol; 1985; 2():151-88. PubMed ID: 2439204 [No Abstract] [Full Text] [Related]
7. [Immunological abnormalities in multiple sclerosis]. Tabira T No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805 [No Abstract] [Full Text] [Related]
8. [Current problems in multiple sclerosis (immunogenetic aspect) (review of the literature)]. Khondkarian OA; Zavalishin IA Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):292-300. PubMed ID: 76384 [No Abstract] [Full Text] [Related]
11. The role of B cells in the immunopathogenesis of multiple sclerosis. Gharibi T; Babaloo Z; Hosseini A; Marofi F; Ebrahimi-Kalan A; Jahandideh S; Baradaran B Immunology; 2020 Aug; 160(4):325-335. PubMed ID: 32249925 [TBL] [Abstract][Full Text] [Related]
12. [Indicators of cellular immunity in patients with multiple sclerosis]. Dziuba AN; Frolov VM; Gaĭdash IS Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):12-4. PubMed ID: 1326155 [TBL] [Abstract][Full Text] [Related]
13. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. O'Connor KC; Bar-Or A; Hafler DA J Clin Immunol; 2001 Mar; 21(2):81-92. PubMed ID: 11332657 [TBL] [Abstract][Full Text] [Related]
14. Which immune cells matter? The immunopathogenesis of multiple sclerosis. Broux B; Stinissen P; Hellings N Crit Rev Immunol; 2013; 33(4):283-306. PubMed ID: 23971528 [TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus: environmental trigger of multiple sclerosis? Lünemann JD; Kamradt T; Martin R; Münz C J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939 [No Abstract] [Full Text] [Related]
16. [Status of local and general immunity in patients with multiple sclerosis]. Totolian NA; Skoromets AA; Barbas IM; Smirnov AIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):20-2. PubMed ID: 1647617 [TBL] [Abstract][Full Text] [Related]
17. Reply to "'Thinking without thinking' about natalizumab and PML". Houff S; Berger JR J Neurol Sci; 2008 Jan; 264(1-2):198-9; author reply 199. PubMed ID: 17936798 [No Abstract] [Full Text] [Related]
18. Cerebrospinal fluid T & B lymphocyte responses in exacerbations of multiple sclerosis. Sheremata W; Allen J; Sazant A; Cosgrove JB; Osterland K Trans Am Neurol Assoc; 1976; 101():40-5. PubMed ID: 1088458 [No Abstract] [Full Text] [Related]
19. Immunological features in multiple sclerosis. Lamoureux G; Giard N; Jolicoeur R; Toughlian V; Desrosiers M Br Med J; 1976 Jan; 1(6003):183-6. PubMed ID: 764920 [TBL] [Abstract][Full Text] [Related]
20. [Presentation of selected studies on the disease picture of multiple sclerosis]. Schmidt RM; Neumann V; Kissig B; Kuppe G; Ludewig R Nervenarzt; 1987 Jul; 58(7):403-12. PubMed ID: 3498125 [No Abstract] [Full Text] [Related] [Next] [New Search]